{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T05:58:14Z","timestamp":1769147894093,"version":"3.49.0"},"reference-count":56,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2003,11,1]],"date-time":"2003-11-01T00:00:00Z","timestamp":1067644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>An activated mutation in the FGFR3 gene causes ACH. To examine the effects of IGF-1, which is an important mediator of GH, on apoptosis, we analyzed a chondrogenic cell line expressing the FGFR3 mutants. Our findings that IGF-1 prevented the apoptosis through P13K and MAPK pathways may explain how GH treatment improves the disturbed bone growth in ACH.<\/jats:p>\n               <jats:p>Introduction: Achondroplasia (ACH), which is caused by a point mutation of the fibroblast growth factor receptor 3 (FGFR3) gene in the transmembrane domain (G380R), is one of the most common genetic forms of dwarfism. Recently, using a chondrogenic cell line, ATDC5, we have showed that the constitutively active FGFR3 mutants induced an apoptosis of chondrocytes. We have also reported that growth hormone (GH) treatment increased the growth rate in achondroplasia in parallel with the increment of serum levels of insulin-like growth factor (IGF)-1, suggesting an important role of IGF-1 in skeletal development. In this study, to clarify the mechanism by which GH treatment improved the phenotype of ACH patients, we examined the possible effects of IGF-1 on an apoptosis induced by FGFR3 mutant in ATDC5.<\/jats:p>\n               <jats:p>Materials and Methods: Using adenovirus vector, wildtype or mutant FGFR3 (G380R) was introduced into ATDC5. Analysis of apoptosis was estimated by TUNEL assay. Expression levels of apoptosis-related genes and activation of signaling molecules were analyzed by immunoblot.<\/jats:p>\n               <jats:p>Results: MTT assay showed that the cell number was reduced in ATDC5 cells expressing the mutant FGFR3 (G380R; ATDC5-mtR3 cells), suggesting that ATDC5-mtR3 cells might fall into apoptosis. IGF-1, which is an important mediator of GH, restored cell proliferation and reduced apoptosis in ATDC5-mtR3 cells. IGF-1 also decreased the ratio of Bax\/Bcl-2 in the cells. To investigate which signaling cascade is responsible for antiapoptotic effects of IGF-1, we examined the role of phosphatidylinositol 3-kinase (PI3K) and MAPK in ATDC5-mtR3 cells. Specific inhibitors of PI3K or MAPK blocked the antiapoptotic effects of IGF-1 in ATDC5-mtR3 cells.<\/jats:p>\n               <jats:p>Conclusions: Our findings, showing IGF-1 prevents the apoptosis induced by FGFR3 mutation through the PI3K pathway and MAPK pathway, explain the mechanisms by which GH treatment improves the disturbed bone growth in ACH.<\/jats:p>","DOI":"10.1359\/jbmr.2003.18.11.2043","type":"journal-article","created":{"date-parts":[[2006,4,26]],"date-time":"2006-04-26T21:32:12Z","timestamp":1146087132000},"page":"2043-2051","source":"Crossref","is-referenced-by-count":36,"title":["Insulin-like Growth Factor-1 Rescues the Mutated FGF Receptor 3 (G380R) Expressing ATDC5 Cells From Apoptosis Through Phosphatidylinositol 3-Kinase and MAPK"],"prefix":"10.1093","volume":"18","author":[{"given":"Mio","family":"Koike","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Yamanaka","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riko","family":"Nishimura","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Osaka University Faculty of Dentistry, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Seino","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2009,12,2]]},"reference":[{"key":"2024013019112887000_bib1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1043-2760(98)00120-9","article-title":"Control of Bone growth by fibroblast growth factors","volume":"10","author":"De Luca","year":"1999","journal-title":"Trends Endocrinol Metab"},{"key":"2024013019112887000_bib2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/371252a0","article-title":"Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia","volume":"371","author":"Rousseau","year":"1994","journal-title":"Nature"},{"key":"2024013019112887000_bib3","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0092-8674(94)90302-6","article-title":"Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia","volume":"78","author":"Shiang","year":"1994","journal-title":"Cell"},{"key":"2024013019112887000_bib4","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/ng0395-321","article-title":"Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3","volume":"9","author":"Tavormina","year":"1995","journal-title":"Nat Genet"},{"key":"2024013019112887000_bib5","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1093\/hmg\/4.11.2175","article-title":"Another mutation that results in the substitution of an unpaired cysteine residue in the extracellular domain of FGFR3 in thanatophoric dysplasia type I","volume":"4","author":"Tavormina","year":"1995","journal-title":"Hum Mol Genet"},{"key":"2024013019112887000_bib6","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/ng0795-357","article-title":"A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia","volume":"10","author":"Bellus","year":"1995","journal-title":"Nat Genet"},{"key":"2024013019112887000_bib7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/(SICI)1096-8628(19990702)85:1<53::AID-AJMG10>3.0.CO;2-F","article-title":"Severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN): Phenotypic analysis of a new skeletal dysplasia caused by a Lys650Met mutation in fibroblast growth factor receptor 3","volume":"85","author":"Bellus","year":"1999","journal-title":"Am J Med Genet"},{"key":"2024013019112887000_bib8","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1086\/302275","article-title":"A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene","volume":"64","author":"Tavormina","year":"1999","journal-title":"Am J Hum Genet"},{"key":"2024013019112887000_bib9","first-page":"23","article-title":"The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: The achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans","volume":"21","author":"Vajo","year":"2000","journal-title":"Endocr Rev"},{"key":"2024013019112887000_bib10","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0092-8674(00)81069-7","article-title":"Fibroblast growth factor receptor 3 is a negative regulator of bone growth","volume":"84","author":"Deng","year":"1996","journal-title":"Cell"},{"key":"2024013019112887000_bib11","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/ng0496-390","article-title":"Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3","volume":"12","author":"Colvin","year":"1996","journal-title":"Nat Genet"},{"key":"2024013019112887000_bib12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/ng0696-233","article-title":"Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia","volume":"13","author":"Naski","year":"1996","journal-title":"Nat Genet"},{"key":"2024013019112887000_bib13","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/j.1460-2075.1996.tb00384.x","article-title":"Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia","volume":"15","author":"Webster","year":"1996","journal-title":"EMBO J"},{"key":"2024013019112887000_bib14","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1128\/MCB.16.8.4081","article-title":"Profound ligand-independent kinase activation of fibroblast growth factor receptor 3 by the activation loop mutation responsible for a lethal skeletal dysplasia, thanatophoric dysplasia type II","volume":"16","author":"Webster","year":"1996","journal-title":"Mol Cell Biol"},{"key":"2024013019112887000_bib15","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1242\/dev.125.24.4977","article-title":"Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3","volume":"125","author":"Naski","year":"1998","journal-title":"Development"},{"key":"2024013019112887000_bib16","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.1073\/pnas.96.8.4455","article-title":"A mouse model for achondroplasia produced by targeting fibroblast growth factor receptor 3","volume":"96","author":"Wang","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024013019112887000_bib17","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1172\/JCI6690","article-title":"Gly369Cys mutation in mouse FGFR3 causes achondroplasia by affecting both chondrogenesis and osteogenesis","volume":"104","author":"Chen","year":"1999","journal-title":"J Clin Invest"},{"key":"2024013019112887000_bib18","doi-asserted-by":"crossref","first-page":"13007","DOI":"10.1074\/jbc.273.21.13007","article-title":"Fibroblast growth factor receptor 3 mutations promote apoptosis but do not alter chondrocyte proliferation in thanatophoric dysplasia","volume":"273","author":"Legeai-Mallet","year":"1998","journal-title":"J Biol Chem"},{"key":"2024013019112887000_bib19","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1359\/jbmr.2003.18.8.1395","article-title":"PTHrP rescues ATDC5 cells from apoptosis induced by FGF receptor 3 mutation","volume":"18","author":"Yamanaka","year":"2003","journal-title":"J Bone Miner Res."},{"key":"2024013019112887000_bib20","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1359\/jbmr.1997.12.8.1174","article-title":"Cellular hypertrophy and calcification of embryonal carcinoma-derived chondrogenic cell line ATDC5 in vitro","volume":"12","author":"Shukunami","year":"1997","journal-title":"J Bone Miner Res"},{"key":"2024013019112887000_bib21","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/ajmg.1320420508","article-title":"Growth hormone therapy in achondroplasia","volume":"42","author":"Horton","year":"1992","journal-title":"Am J Med Genet"},{"key":"2024013019112887000_bib22","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1530\/eje.0.1380275","article-title":"Effect of growth hormone therapy in children with achondroplasia: Growth pattern, hypothalamic-pituitary function, and genotype","volume":"138","author":"Tanaka","year":"1998","journal-title":"Eur J Endocrinol"},{"key":"2024013019112887000_bib23","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1651-2227.1999.tb14369.x","article-title":"Molecular defects in achondroplasia and the effects of growth hormone treatment","volume":"88","author":"Seino","year":"1999","journal-title":"Acta Paediatr Suppl"},{"key":"2024013019112887000_bib24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/235107a0","article-title":"Somatomedin: Proposed designation for sulphation factor","volume":"235","author":"Daughaday","year":"1972","journal-title":"Nature"},{"key":"2024013019112887000_bib25","doi-asserted-by":"crossref","first-page":"7088","DOI":"10.1073\/pnas.96.12.7088","article-title":"Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice","volume":"96","author":"Sjogren","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024013019112887000_bib26","doi-asserted-by":"crossref","first-page":"7324","DOI":"10.1073\/pnas.96.13.7324","article-title":"Normal growth and development in the absence of hepatic insulin-like growth factor I","volume":"96","author":"Yakar","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024013019112887000_bib27","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1210\/edrv-10-1-68","article-title":"Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations","volume":"10","author":"Daughaday","year":"1989","journal-title":"Endocr Rev"},{"key":"2024013019112887000_bib28","doi-asserted-by":"crossref","first-page":"6653","DOI":"10.1074\/jbc.272.10.6653","article-title":"The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways","volume":"272","author":"Coolican","year":"1997","journal-title":"J Biol Chem"},{"key":"2024013019112887000_bib29","doi-asserted-by":"crossref","first-page":"19115","DOI":"10.1074\/jbc.272.31.19115","article-title":"Insulin-like growth factor-I rapidly activates multiple signal transduction pathways in cultured rat cardiac myocytes","volume":"272","author":"Foncea","year":"1997","journal-title":"J Biol Chem"},{"key":"2024013019112887000_bib30","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1074\/jbc.272.1.154","article-title":"Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 3\u2032-kinase and mitogen-activated protein kinase pathways","volume":"272","author":"Parrizas","year":"1997","journal-title":"J Biol Chem"},{"key":"2024013019112887000_bib31","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1210\/endo.137.10.8828504","article-title":"Comparison of the insulin and insulin-like growth factor 1 mitogenic intracellular signaling pathways","volume":"137","author":"Sasaoka","year":"1996","journal-title":"Endocrinology"},{"key":"2024013019112887000_bib32","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1210\/endo.137.3.8603569","article-title":"Interaction of the molecular weight 85K regulatory subunit of the phosphatidylinositol 3-kinase with the insulin receptor and the insulin-like growth factor-1 (IGF- I) receptor: Comparative study using the yeast two-hybrid system","volume":"137","author":"Tartare-Deckert","year":"1996","journal-title":"Endocrinology"},{"key":"2024013019112887000_bib33","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1006\/excr.1996.0202","article-title":"The synergistic effect of PDGF-AA and IGF-1 on VSMC proliferation might be explained by the differential activation of their intracellular signaling pathways","volume":"226","author":"Thommes","year":"1996","journal-title":"Exp Cell Res"},{"key":"2024013019112887000_bib34","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1073\/pnas.88.4.1095","article-title":"Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3","volume":"88","author":"Keegan","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024013019112887000_bib35","doi-asserted-by":"crossref","first-page":"6621","DOI":"10.1074\/jbc.272.10.6621","article-title":"Signal transduction pathway of human fibroblast growth factor receptor 3. Identification of a novel 66-kDa phosphoprotein","volume":"272","author":"Kanai","year":"1997","journal-title":"J Biol Chem"},{"key":"2024013019112887000_bib36","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.281.5381.1309","article-title":"Mitochondria and apoptosis","volume":"281","author":"Green","year":"1998","journal-title":"Science"},{"key":"2024013019112887000_bib37","doi-asserted-by":"crossref","first-page":"31179","DOI":"10.1074\/jbc.274.44.31179","article-title":"Insulin receptor substrate-4 enhances insulin-like growth factor-I- induced cell proliferation","volume":"274","author":"Qu","year":"1999","journal-title":"J Biol Chem"},{"key":"2024013019112887000_bib38","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/(SICI)1097-4547(19990801)57:3<332::AID-JNR5>3.0.CO;2-0","article-title":"Phosphatidylinositol 3-kinase and Akt protein kinase mediate IGF-I- and prosaptide-induced survival in Schwann cells","volume":"57","author":"Campana","year":"1999","journal-title":"J Neurosci Res"},{"key":"2024013019112887000_bib39","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1210\/endo.140.2.6539","article-title":"Requirement for phosphatidylinositol-3\u2032-kinase in cytokine-mediated germ cell survival during fetal oogenesis in the mouse","volume":"140","author":"Morita","year":"1999","journal-title":"Endocrinology"},{"key":"2024013019112887000_bib40","first-page":"939","article-title":"Identification of structural characteristics that contribute to a difference in antiapoptotic function between human insulin and insulin-like growth factor 1 receptors","volume":"9","author":"Chen","year":"1998","journal-title":"Cell Growth Differ"},{"key":"2024013019112887000_bib41","doi-asserted-by":"crossref","first-page":"27489","DOI":"10.1074\/jbc.270.46.27489","article-title":"PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo","volume":"270","author":"Alessi","year":"1995","journal-title":"J Biol Chem"},{"key":"2024013019112887000_bib42","doi-asserted-by":"crossref","first-page":"13585","DOI":"10.1074\/jbc.270.23.13585","article-title":"Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor","volume":"270","author":"Pang","year":"1995","journal-title":"J Biol Chem"},{"key":"2024013019112887000_bib43","doi-asserted-by":"crossref","first-page":"5739","DOI":"10.1128\/MCB.17.10.5739","article-title":"Enhanced signaling and morphological transformation by a membrane- localized derivative of the fibroblast growth factor receptor 3 kinase domain","volume":"17","author":"Webster","year":"1997","journal-title":"Mol Cell Biol"},{"issue":"Suppl 3","key":"2024013019112887000_bib44","first-page":"53","article-title":"Growth hormone therapy in achondroplasia","volume":"53","author":"Seino","year":"2000","journal-title":"Horm Res"},{"key":"2024013019112887000_bib45","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0092-8674(92)90531-G","article-title":"Cell death and control of cell survival in the oligodendrocyte lineage","volume":"70","author":"Barres","year":"1992","journal-title":"Cell"},{"key":"2024013019112887000_bib46","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1460-9568.1995.tb01022.x","article-title":"Fibroblast growth factors and insulin growth factors combine to promote survival of rat Schwann cell precursors without induction of DNA synthesis","volume":"7","author":"Gavrilovic","year":"1995","journal-title":"Eur J Neurosci"},{"key":"2024013019112887000_bib47","doi-asserted-by":"crossref","first-page":"26699","DOI":"10.1074\/jbc.M102664200","article-title":"Insulin-like growth factor 1 (IGF-1)-induced Twist expression is involved in the anti-apoptotic effects of the IGF-1 receptor","volume":"276","author":"Dupont","year":"2001","journal-title":"J Biol Chem"},{"key":"2024013019112887000_bib48","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/376037a0","article-title":"Identification and inhibition of the ICE\/CED-3 protease necessary for mammalian apoptosis","volume":"376","author":"Nicholson","year":"1995","journal-title":"Nature"},{"key":"2024013019112887000_bib49","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/00001622-199511000-00012","article-title":"Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance","volume":"7","author":"Reed","year":"1995","journal-title":"Curr Opin Oncol"},{"key":"2024013019112887000_bib50","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1042\/bst0241059","article-title":"Cell death signal transduction and Bcl-2 function","volume":"24","author":"Herrmann","year":"1996","journal-title":"Biochem Soc Trans"},{"key":"2024013019112887000_bib51","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1006\/jmcc.1994.1115","article-title":"Hypothesis: Apoptosis may be a mechanism for the transition to heart failure with chronic pressure overload","volume":"26","author":"Bing","year":"1994","journal-title":"J Mol Cell Cardiol"},{"key":"2024013019112887000_bib52","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1210\/endo.138.3.5103","article-title":"Insulin-like growth factor-1 inhibition of apoptosis is associated with increased expression of the bcl-xL gene product","volume":"138","author":"Parrizas","year":"1997","journal-title":"Endocrinology"},{"key":"2024013019112887000_bib53","first-page":"3","article-title":"Insulin-like growth factors and their binding proteins: Biological actions","volume":"16","author":"Jones","year":"1995","journal-title":"Endocr Rev"},{"key":"2024013019112887000_bib54","doi-asserted-by":"crossref","first-page":"9847","DOI":"10.1074\/jbc.272.15.9847","article-title":"Inhibition of phosphatidylinositol 3-kinase activity blocks depolarization- and insulin-like growth factor I-mediated survival of cerebellar granule cells","volume":"272","author":"Miller","year":"1997","journal-title":"J Biol Chem"},{"key":"2024013019112887000_bib55","first-page":"G151","article-title":"IGF-I stimulates intestinal muscle cell growth by activating distinct PI 3-kinase and MAP kinase pathways","volume":"275","author":"Kuemmerle","year":"1998","journal-title":"Am J Physiol"},{"key":"2024013019112887000_bib56","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.4049\/jimmunol.160.3.1393","article-title":"Activation of protein kinase C-zeta and phosphatidylinositol 3\u2032-kinase and promotion of macrophage differentiation by insulin-like growth factor-I","volume":"160","author":"Liu","year":"1998","journal-title":"J Immunol"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1359%2Fjbmr.2003.18.11.2043","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/18\/11\/2043\/56469320\/5650181116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/18\/11\/2043\/56469320\/5650181116.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T15:06:11Z","timestamp":1710342371000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/18\/11\/2043-2051\/7592279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11,1]]},"references-count":56,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2009,12,2]]},"published-print":{"date-parts":[[2003,11,1]]}},"URL":"https:\/\/doi.org\/10.1359\/jbmr.2003.18.11.2043","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2003,11,1]]},"published":{"date-parts":[[2003,11,1]]}}}